Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the ...

Other delayed listings include pharmaceutical company Stada and car parts seller Autodoc, both of which have cited either ...

It comes amid reports that the drugs maker is considering moving its listing from the UK to the US in what would be a hammer ...

COMMENT: There’s already been a mass exodus of investors as they gravitate towards the welcoming arms of New York, writes .

LONDON, GREATER LONDON, UNITED KINGDOM, July 4, 2025 /EINPresswire.com/ -- The anti-inflammatory drugs market size has grown rapidly in recent years. From $136.86 billion in 2024, it is predicted to ...

The FTSE 100 index finished virtually flat, slipping just 0.003% to close at 8,822.91 points, while the FTSE 250 dropped 0.67% to 21,557.34 points. In currency markets, sterling was last down 0.04% on ...